Brillian Pharma

Brillian Pharma is a private pediatric-focused drug delivery company that combines a proprietary technology platform with integrated global manufacturing capabilities. The company aims to adapt adult medications for children through innovative formulation and delivery science, operating from R&D in the US to commercial-scale production in China. With a leadership team experienced in pharma development and operations, Brillian positions itself as a specialized partner for pediatric product development, though it appears to be in a pre-revenue or early development stage without a disclosed clinical pipeline.

Proprietary drug delivery technology platform (SD® technology) focused on reformulating and developing age-appropriate dosage forms for pediatric patients, enabling the use of medicines previously limited to adults.

Brillian competes in the specialized pediatric drug delivery and development services space against other formulation-focused CROs, CDMOs, and biotech platforms. Its differentiation is based on its dedicated pediatric focus, proprietary SD® platform, and claimed closed-loop development-to-commercial production capability, particularly with cost-effective manufacturing scale in China.